Viva Biotech Holdings (FRA:VB0)

Market Cap	451.50M
Revenue (ttm)	218.31M
Net Income (ttm)	20.48M
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	22.05
Forward PE	6.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	482
Open	0.1860
Previous Close	0.1910
Day's Range	0.1860 - 0.1860
52-Week Range	0.0860 - 0.3420
Beta	n/a
RSI	49.86
Earnings Date	Mar 29, 2026

About Viva Biotech Holdings

Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacology and DMPK; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemica...

• Industry: Commercial Physical and Biological Research
• Founded: 2008
• Employees: 2,063
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: VB0

Financial Performance

Financial numbers in CNY